Technical Analysis for ATHA - Athira Pharma, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
F | 0.61 | 41.53% | 0.18 |
ATHA closed up 41.53 percent on Friday, November 1, 2024, on 40.54 times normal volume. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.
Earnings due: Nov 7
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Down | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Shooting Star Candlestick | Bearish | 0.00% | |
Crossed Above 20 DMA | Bullish | 0.00% | |
New Uptrend | Bullish | 0.00% | |
Pocket Pivot | Bullish Swing Setup | 0.00% | |
Volume Surge | Other | 0.00% | |
Wide Range Bar | Range Expansion | 0.00% | |
Doji - Bearish? | Reversal | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Above Upper BB | Strength | 0.00% | |
Gapped Up | Strength | 0.00% |
Alert | Time |
---|---|
Rose Above 20 DMA | about 21 hours ago |
Rose Above Previous Day's High | about 21 hours ago |
Rose Above Upper Bollinger Band | about 21 hours ago |
Rose Above 10 DMA | about 21 hours ago |
2x Volume Pace | about 21 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/07/2024
Athira, headquartered in Seattle, is a drug development company striving to improve human health by advancing bold and innovative therapies with the potential to restore the lives of people impacted by brain disorders. Athira is currently advancing its lead therapeutic candidate, NDX-1017, a novel small molecule therapeutic, in later-stage clinical trials for Alzheimer’s.
Sector: Healthcare
Industry: Biotechnology
Keywords: Drug Development Nasdaq 100 Index Innovative Therapies Brain Disorders
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Drug Development Nasdaq 100 Index Innovative Therapies Brain Disorders
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 4.2984 |
52 Week Low | 0.4115 |
Average Volume | 5,906,918 |
200-Day Moving Average | 2.34 |
50-Day Moving Average | 0.85 |
20-Day Moving Average | 0.46 |
10-Day Moving Average | 0.49 |
Average True Range | 0.08 |
RSI (14) | 52.61 |
ADX | 35.6 |
+DI | 41.11 |
-DI | 19.20 |
Chandelier Exit (Long, 3 ATRs) | 0.52 |
Chandelier Exit (Short, 3 ATRs) | 0.64 |
Upper Bollinger Bands | 0.55 |
Lower Bollinger Band | 0.38 |
Percent B (%b) | 1.34 |
BandWidth | 37.22 |
MACD Line | -0.08 |
MACD Signal Line | -0.13 |
MACD Histogram | 0.0492 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.91 | ||||
Resistance 3 (R3) | 0.92 | 0.84 | 0.86 | ||
Resistance 2 (R2) | 0.84 | 0.76 | 0.83 | 0.84 | |
Resistance 1 (R1) | 0.72 | 0.71 | 0.78 | 0.71 | 0.83 |
Pivot Point | 0.63 | 0.63 | 0.66 | 0.63 | 0.63 |
Support 1 (S1) | 0.52 | 0.55 | 0.57 | 0.50 | 0.39 |
Support 2 (S2) | 0.43 | 0.51 | 0.42 | 0.37 | |
Support 3 (S3) | 0.31 | 0.43 | 0.35 | ||
Support 4 (S4) | 0.30 |